Tesla Faces Dual Headwinds: Regulatory Deadline and Legal Testimony Converge

Tesla’s stock is navigating turbulent skies this week, caught between a looming regulatory deadline and high-stakes courtroom testimony from its CEO. This confluence of legal and oversight pressures is creating significant near-term uncertainty for the electric vehicle maker’s equity.

Musk Testifies as Shareholder Lawsuit Proceeds

Adding to the corporate agenda, Elon Musk is currently providing testimony in a San Francisco courtroom. He faces allegations from former Twitter shareholders that he made false or misleading statements concerning bot issues on the platform in 2022. The plaintiffs, who sold their Twitter shares between May 13 and October 4, 2022, contend these statements artificially depressed the stock price ahead of his acquisition of the company.

The core of the lawsuit alleges Musk threatened to abandon the deal to pressure Twitter’s board into accepting a lower purchase price. In his defense, Musk has rejected the characterization that he leveraged his social media influence to intentionally drive down the share value. With the court schedule extending to March 19, headlines from this legal proceeding are likely to persist.

March 9: A Critical Date for Full Self-Driving

Investor attention is sharply focused on an imminent regulatory milestone. Tesla must submit comprehensive documentation to the National Highway Traffic Safety Administration (NHTSA) by March 9. This submission is part of an ongoing investigation into potential traffic violations involving its Full Self-Driving (FSD) software. Having already received two extensions, the company now has little room for further delay.

The agency has requested specific data, including crash videos, CAN-bus logs, and event data recorder information related to incidents involving newer FSD iterations. Market observers are less concerned with positive spin; the critical factor is whether the filing appears complete, consistent, and thoroughly documented. An inadequate submission could trigger fines, recalls, or delays for Tesla’s ambitions to expand unsupervised FSD testing and its robotaxi initiatives.

This scrutiny follows NHTSA data indicating Tesla robotaxis have been involved in 14 accidents since the service launched in Austin in June 2025. The five most recent incidents in December and January resulted in property damage but no injuries. Two earlier occurrences in July and October led to minor injuries.

Operational Performance Reveals a Diverging Story

Tesla’s latest financial results painted a picture of contrasting business segments. While the company surpassed fourth-quarter earnings estimates (reporting adjusted earnings of $0.50 per share versus expectations of $0.45) and posted revenue of $24.90 billion, slightly above forecasts, underlying figures showed clear divergence.

Should investors sell immediately? Or is it worth buying Tesla?

A concerning trend emerged in automotive operations: vehicle deliveries dropped by 16% for the quarter, and annual revenue declined by 3%—marking the first yearly decrease on record. The slowdown was particularly pronounced in Europe, where registrations fell 48% year-over-year.

In contrast, the energy storage division demonstrated robust stability. Revenue in this segment grew to $12.77 billion in 2025, a 27% increase. Fourth-quarter energy revenue reached $3.84 billion, up 25%. The segment also achieved a quarterly gross margin of 28.7%, generating a record $1.1 billion in gross profit. Looking ahead, Tesla has outlined capital expenditure plans of over $20 billion for 2026 to fund expansion in artificial intelligence, robotics, and semiconductor infrastructure.

Valuation and Competitive Landscape Pose Risks

Several risk factors underscore the current investment thesis. Tesla’s reliance on its Giga Shanghai plant creates vulnerability to shifts in U.S.-China trade policy. Furthermore, declining wait times for vehicles in China—now just 1 to 3 weeks—coupled with rising competitive pressure from local models like the Xiaomi SU7, point to a more challenging demand environment.

The company’s premium valuation remains a focal point for analysts. Tesla’s trailing price-to-earnings (P/E) ratio stands at approximately 375, significantly above its 10-year median of 139. Its price-to-sales ratio is roughly 15.9. These multiples highlight the substantial future growth—particularly in autonomous driving—already priced into the stock.

Market Outlook: Near-Term Focus on Regulatory Clarity

This uncertainty is reflected in the stock’s technical performance. Shares recently traded at €343.15, approximately 6% below the 50-day moving average. In the immediate term, the primary catalyst will likely be whether Tesla navigates the NHTSA submission on March 9 without triggering additional regulatory complications.

Beyond that date, the next operational phase comes into view. The company intends to expand its FSD testing fleet to seven additional U.S. markets in the first half of 2026. This expansion is viewed as crucial for scaling the data collection and real-world testing needed to advance its autonomous driving narrative.